Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat-Reference-Cited by-同舟云学术

Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat

Published:2000-09 Issue:2 Volume:131 Page:173-176
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Escott K J,Belvisi M G,Birrell M A,Webber S E,Foster M L,Sargent C A

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0703605/fullpdf

Reference18 articles.

1. Specific inhibitors of p38 and extracellular signal-regulated kinase and mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma;AJIZIAN;J. Infect. Dis.,1999

2. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxic shock and immune function;BADGER;J. Pharmacol. Exp. Ther.,1996

3. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes;BADGER;J. Immunol.,1998

4. Effect of the p38 kinase inhibitor, SB 203580, in a model of airway inflammation;BIRRELL;Br. J. Pharmacol.,1998

5. Cytokines in symptomatic asthma airways;BROIDE;J. Allergy Clin. Immunol.,1992

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. House dust mite allergen Der f 2 drives IL-6 and GM–CSF expression in airway epithelial cells via p38 MAPK/NF-κB signaling;Journal of Asthma;2024-05-23

2. The future drug treatment of COPD;COPD in the 21st Century;2024-03-01

3. NJK14047 Suppression of the p38 MAPK Ameliorates OVA-Induced Allergic Asthma during Sensitization and Challenge Periods;Biomolecules & Therapeutics;2022-09-29

4. Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD;Frontiers in Pharmacology;2022-09-28

5. p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice;Biomolecules & Therapeutics;2022-07-05